Ascendis

MBX aims for $136M IPO to take potential rival to Ascendis' Yorvipath into phase 3
Fierce Biotech
Mon, 09/9/24 - 07:10 pm
MBX Biosciences
IPOs
Yorvipath
Ascendis
Ascendis sells Japanese rights to Skytrofa and two other hormone drugs for $70M upfront
Fierce Biotech
Thu, 11/30/23 - 10:19 am
Ascendis
Japan
Skytrofa
growth hormone
Teijin Pharma
Biotech’s near-term key catalysts
EP Vantage
Thu, 09/29/22 - 09:45 am
Biogen
Eisai
Alzheimer's disease
Arrowhead Pharmaceuticals
Takeda
RNAi
Madrigal
NASH
Ascendis
FDA
FDA pushes back Ascendis' PDUFA for long-acting hormone therapy
Endpoints
Mon, 06/14/21 - 11:49 pm
Ascendis
FDA
pediatric growth hormone deficiency
5 Biotech Stocks Set to Beat Q3 Earnings Estimates
Yahoo/Zacks.com
Tue, 11/12/19 - 10:20 am
earnings
biotech
Eyenovia
SAGE Therapeutics
AC Immune
Ascendis
NGM Biopharmaceuticals
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
Sun, 03/24/19 - 12:02 pm
FDA
Novartis
Ascendis
Eiger BioPharmaceuticals
Proteostasis Therapeutics
Fibrocell Science
Supernus Pharmaceuticals
FibroGen
INSYS Therapeutics
Ascendis jumps on Phase III readout for once-weekly growth hormone
BioCentury
Mon, 03/4/19 - 05:14 pm
Ascendis
TransCon hGH
pediatric growth hormone deficiency
clinical trials
Upcoming events – Ascendis and Lilly hope for growth with pivotal data
EP Vantage
Fri, 02/1/19 - 11:58 am
Ascendis
clinical trials
pediatric growth hormone deficiency
TransCon hGH
Eli Lilly
olumiant
eczema
Last Week's Biotech IPO Recap
Yahoo/Benzinga
Tue, 02/3/15 - 10:37 am
biotech
IPOs
Zosano
Ascendis
Presbia
Flex Pharma
Entellus Medical
Spark Therapeutics
TRACON Pharmaceuticals
Avinger
4 More Biotech IPOs Going Public This Week
Yahoo/Benzinga
Wed, 01/28/15 - 08:42 am
IPOs
biotech
Ascendis
EyeGate Pharma
Entellus Medical
Flex Pharma
Novo Nordisk, Lilly, Novartis Said to Bid for Ascendis Pharma
Bloomberg Businessweek
Fri, 07/30/10 - 10:55 am
Novo Nordisk
Eli Lilly
Novartis
Ascendis
M&A